Additional file 1: Table S1. of Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study Thomas Bertelmann Nicolas Feltgen Martin Scheffler Ulrich Hufenbach Annette Wiedon Helmut Wilhelm Focke Ziemssen 10.6084/m9.figshare.c.3607322_D1.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Vision-related_quality_of_life_in_patients_receiving_intravitreal_ranibizumab_injections_in_routine_clinical_practice_baseline_data_from_the_German_OCEAN_study/4351370 Mean baseline NEI VFQ-25 composite scores and study periods for OCEAN (treatment-naĂŻve participants) and for pivotal clinical trials of ranibizumab, by indication (nAMD, DME, BRVO, CRVO). (DOCX 23 kb) 2016-09-20 05:00:00 Age-related macular degeneration Diabetic macular edema Retinal vein occlusion Real-world evidence Ranibizumab OCEAN study Anti-VEGF Intravitreal injection Visual acuity (VA) Optical coherence tomography (OCT)